Covid-19 vaccine: US begins inoculation program

Covid-19 vaccine
Mass vaccination has begun in the United States. | Photo: Getty Images

Washington, U.S – The United States of America has started their first Covid-19 vaccine inoculation program using the vaccine created by a pharmaceutical corporation, Pfizer and their German partner BioNTech which has proven to be 95% effective in its Phase 3 trial.

While the Food and Drug Administration (FDA) of the United States had approved the emergency use of Pfizer Covid-19 vaccine last week, they have finally begun their first mass vaccination program in different states of the country.

While US is the worst Covid-19 affected country in the whole world, it has killed over 300,000 people in the country. However, the country is finally taking a hopeful step for the people and the future of the country.

I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history.

Sandra Lindsay, the first to get vaccinated in US outside vaccine trial.

Although there are lots of Americans who does not wish to get vaccinated, the country and the officials are still working to prove that the vaccine is safe to use.

At present, the United States has transported nearly three million doses of Pfizer vaccine to hospitals in all 50 states and the vaccination program had started in 145 sites on Monday onwards.

The majority of the vaccines that were given on the first day of the inoculation program was given to high-risk health care workers. As the vaccine is expected to have certain side effects such as fevers and aches, the US has distributed the days in which individual doctors, nurses, security guards, receptionists and other workers who risk being exposed to the virus every day will be inoculated.

While the vaccination of elderly people are also expected to begin next week, US revealed that the vast majority of Americans are expected to receive the vaccine by March 2021 or later.

Pfizer said that currently they are aiming to manufacture 50 million doses of their vaccine in 2020 and 1.3 billion in the upcoming year. If the company is successful in doing so, the fear of the Covid-19 pandemic will finally come to an end before the year 2021 starts.

Pfizer and their German partner BioNTech recently claimed that the Covid-19 vaccine they have made has proven to be 95% effective. The latest data revealed by these companies showed that their vaccine has overall proven to be 95% effective and 94% effective for the volunteers who were over the age of 65 – the individuals who have a weaker immune system compared to youngsters and are at the most risk from the virus.

This is a huge success for these companies as most of the vaccines that were made has proven to be considerably less effective among older people.

While the Pfizer vaccine has already been given regulatory approval by several countries including the UK, Canada, Bahrain and Saudi Arabia, these countries will also be giving priority in vaccinating the elderly, health workers and emergency crew first.